| INTRODUC TI ON
According to the "free hormone hypothesis," the biological activity of hormones is assigned to the fraction that is not bound to plasma proteins. 1 This would imply that the total hormone concentration may not always provide an accurate readout of hormone activity, particularly in the presence of altered binding protein concentrations. Although widely accepted in endocrinology, the "free hormone hypothesis" still lacks robust experimental proof. Recently, support for this hypothesis for sex hormones has been provided using a transgenic mouse model overexpressing the human sex hormone-binding globulin (SHBG). 2 As compared to wild-type controls, SHBG-transgenic animals had similar free T (FT) levels, but significantly higher total testosterone (TT) and luteinizing hormone (LH).
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Despite the high TT, these animals displayed features consistent with mild androgen deficiency, 2 thus supporting the view that TT does not accurately reflect androgen status in the presence of SHBG abnormalities. Compelling support for the free hormone hypothesis also comes from patients with naturally occurring mutations in the SHBG gene. In a young man who carried a missense mutation in SHBG gene resulting in extremely low/undetectable levels of SHBG, 3 TT was very low whereas FT and LH were normal. Despite this, sexual development, secondary sexual characteristics and semen parameters were normal. Conversely, women with normal T and very low SHBG, due to SHBG gene mutations, were reported to have features of hyperandrogenism. 4, 5 The relative roles of TT and FT in the assessment of androgen deficiency have not been extensively investigated. At present, the diagnosis of androgen deficiency in symptomatic men relies largely on TT. 6, 7 The use of FT is tentatively limited to symptomatic men with borderline TT and/or conditions known to affect SHBG, 6, 7 a recommendation based more on expert opinion than hard data. There is an urgent need for more and better clinical and experimental evidence to assess the role of FT as an independent biomarker of androgen function. Recently, a crosssectional analysis of the European Male Ageing Study (EMAS) reported a higher probability of androgen deficiency symptoms in men with low FT and low TT but not in men with normal FT and low TT. 8 This strongly supports the view that documenting low FT (in addition to low TT) can improve the accuracy of diagnosing symptomatic hypogonadism.
In a prospective analysis of the EMAS, 9 we showed that obese eugonadal men are at increased risks for developing biochemical secondary hypogonadism (SH) with a concomitant deterioration in 
Conclusions:
These longitudinal data demonstrate the importance of FT in the diagnosis of hypogonadism in obese men with low TT and SHBG. The concurrent fall in TT and FT identifies the minority (27.3%) of men with hypogonadal symptoms, which were not present in the majority developing low TT with normal FT.
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However, SH was defined according to TT and it is unclear whether lower SHBG may have contributed to the observed decline in TT (without a concomitant fall in FT), thereby potentially inflating the incidence/diagnosis of SH in obese men.
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We hypothesize that the addition of FT to TT in the categorization of SH can improve the precision in identifying men who develop not only biochemical SH but also accompanying features of androgen deficiency. Hence, the aim of this study was to compare and contrast the natural history and clinical characteristics of developing SH as defined by low TT with low FT and low TT but normal FT.
| MATERIAL S AND ME THODS

| Participants and study design
The study design and methods of the EMAS have been previously described extensively. 11, 12 Briefly, EMAS is a multicentre, prospective, population-based survey on an age-stratified sample of 3369 unselected community-dwelling men aged 40-79 years (mean ± standard deviation 60 ± 11) recruited from population registers in eight European centres: 
| Hormone measurements
| Gonadal status
In keeping with previous EMAS classifications, 9, 14, 16 As a validated reference range for FT is lacking, 17 we conducted exploratory analyses on our sample in order to identify an appropriate FT threshold. We modelled logistic regressions using incident low FT as the independent variable (with persistent normal FT as ref- In addition, it confirmed our previous cross-sectional analyses. 13 We therefore selected the FT threshold of 170 pmol/L for constructing the operational definition of SH in the present analyses.
| Statistical analysis
The differences between the analytical groups were initially assessed by the analysis of variance and chi-squared tests for continuous and categorical variables, respectively. Post hoc analyses were performed using the TukeyKramer test and Z test with correction for multiple pairwise comparisons.
Multilevel binary logistic regression models were used to assess the associations between nine putative predictors 9,14 and changes in gonadal status (transition from eugonadism to SH) as outcomes, with PE being the referent category. The relationship between change in gonadal status and change in clinical features of hypogonadism was assessed by binary logistic regression models with nine putative symptoms of hypogonadism as outcomes. 9, 14 Results from logistic regressions are presented as odds ratios (ORs) and 95% confidence intervals (CIs). With respect to the recovery from LNSH and LLSH to eugonadism, the small sample size allowed only the assessment and comparison of recovery rates. All statistical analyses were conducted using Stata SE 13.1 (StataCorp, College Station, TX, USA).
A P-value <.05 was considered as significant. Table S1 . 2019 eugonadal men at baseline were included in the analytical sample for capturing progression to SH, while 217 men who already had SH at baseline were considered only for describing recovery rates.
| RE SULTS
| Gonadal status transition
Of the 2019 EUG men at baseline, 1880 were classified as PE at follow-up, 139 developed SH, of whom 101 (72.7%) had FT ≥170 pmol/L (LNSH) and 38 (27.3%) had FT <170 pmol/L (LLSH) (Figure 1 ). Incidence for LNSH and LLSH was 4.9% and 1.9%, respectively, over 4.3 years.
Assuming linearity of transition, this translates to an LNSH incidence rate of 114.5 per 10 000 per year, or 1.1% per annum and for an LLSH incidence rate of 43.1 per 10 000 per year, or 0.4% per annum.
| Characteristics of the analytical groups
Incident LNSH men were younger than incident LLSH subjects (Table 1 ). No differences in education level, marital status, smoking habits and alcohol intake at baseline and follow-up were found between the three groups ( Table 1) . .564
Smoking, n (%) .004
Diabetes, n (%) .039
Overall sexual function 22.2 ± 6.5
23.1 ± 6.4
19.9 ± 6.9
.073
21. Educated to less than a university degree level.
e Data differ significantly (P < .05) from the PE group using the Tukey-Kramer test for continuous variables or the z test for categorical variables with correction for multiple pairwise comparisons.
*, **, ***Data differ significantly (P < .05, P < .01 and P < .001, respectively) from baseline values within the same group when analysed using paired t tests (for continuous variables) or the McNemar test (for categorical variables).
TA B L E 1 (Continued)
| Hormone levels
At baseline, by definition, all men had TT and FT within the normal range, although their levels were already significantly lower in incident LNSH and LLSH than in PE (Table 1 ). SHBG at baseline was the lowest in incident LNSH, whereas incident LLSH had intermediate levels and PE men had the highest (Table 1) . At follow-up, the differences in SHBG between the three groups followed those found at baseline. SHBG had different trends over time in the three groups, being significantly increased in PE, decreased in incident LNSH and unchanged in incident LLSH.
| Anthropometrics and metabolic parameters
At baseline, both incident LNSH and LLSH men had significantly greater BMI, waist circumference (WC) and body weight than PE subjects (Table 1) . At follow-up, the differences in BMI and WC between PE and both the incident SH groups were even greater. Incident LNSH was characterized at baseline by higher triglycerides than PE, whereas incident LLSH had lower HDL cholesterol and higher HOMA-IR than PE, with a trend towards higher fasting glucose (Table 1) . At follow-up, the metabolic pattern of incident LNSH men significantly worsened, with higher fasting glucose and HOMA-IR and triglycerides as well as lower HDL cholesterol compared to PE. In contrast, incident LLSH men maintained their metabolic profile largely unchanged (Table 1) .
Both the SH groups showed a higher prevalence of cardiovascular diseases (CVDs) than PE, particularly at follow-up (Table 1 ).
| Predictors of incident LNSH
Multiple logistic regression analysis showed that overweight and obesity at baseline were both significant risk factors for transition from eugonadism to LNSH (OR = 2. 
| Predictors of incident LLSH
Obesity ( 
| Symptoms associated with incident LNSH
There was no difference in sexual, physical or psychological symptoms between incident LNSH and PE men (Table 1) at baseline or follow-up. This was confirmed after adjusting for confounders (age, centre, BMI, comorbidity and smoking) (Figure 2 ). Accordingly, there was also no difference in the change (development/worsening) of symptoms during follow-up.
| Symptoms associated with incident LLSH
At baseline, prevalence of symptoms was not different between incident LLSH and PE men before (Table 1 ) and after adjustment for confounders ( Figure 2) . However, at follow-up, incident LLSH men reported all three sexual symptoms (erectile dysfunction, decrease in sexual thoughts and decreased morning erections) more frequently.
Accordingly, development/worsening of sexual symptoms also occurred more frequently in incident LLSH men. Lack of vigour was found also to be increased over time in incident LLSH, but this attenuated after adjustment for comorbidity and smoking (Table S2) .
No other associations between LLSH and physical or psychological symptoms were found (Figure 2 ).
| Recovery from LNSH or LLSH
Of the 224 men with prevalent SH at baseline, 173 (77.2%) were LNSH and 51 (22.8%) LLSH (Table 3) . Recovery from LNSH to Multiple logistic regression analysis of incident secondary hypogonadal groups (using persistent eugonadism as referent) in relation to risk factors. Data are expressed as odds ratio ±95% confidence interval. BMI categories considered were BMI: 25-30 (overweight) and BMI ≥30 kg/m 2 (obese). Referent categories for predictors included in the analysis: Age >70 y; no comorbidities; BMI <25 kg/m 2 ; no chronic pain; no current smoking; infrequent alcohol intake: alcohol intake for less than 5 d/wk; educated to a university degree level; No partner or not living together with a partner; PASE >78. LNSH, low total testosterone/normal free testosterone secondary hypogonadism; LLSH, low total testosterone/low free testosterone secondary hypogonadism; BMI, Body Mass Index; PASE, Physical Activity Scale for the Elderly. Level of statistical significance is denoted by italic characters and *P < .05, **P < .01 and ***P < .001. 
| D ISCUSS I ON
In a previous longitudinal analysis of the EMAS population, we found increased sexual symptoms in men who developed SH as defined by the decline in TT. 9 We have also shown previously, in a crosssectional analysis of the entire EMAS cohort, that adding FT to TT yielded stronger associations with clinical feature of androgen deficiency than TT alone, which can be influenced by variations in SHBG. of SH. 9 In the present analysis, we were able to show additionally that LNSH typically develops in younger men, whereas age is not a significant predictor for the development of LLSH. Furthermore, a different natural history was revealed, with a significantly higher proportion of men recovering to eugonadism in LNSH than LLSH (46.2% vs 27.5%, P = .017) over 4.3 years.
Since sexual symptoms are considered the cardinal features of adult hypogonadism, 13, 19 our findings indicate that low FT, in combination with low TT, provides the best discriminatory metric for detecting androgen deficiency. Furthermore, the association with sexual symptoms suggests that LLSH only should be regarded as a genuine form of hypogonadism. In contrast, the clinical features associated with the development of LNSH are indistinguishable from that of PE,
Relationship between change in gonadal status and clinical symptoms. Logistic regression analysis of clinical symptoms (outcome variables) in relation to incident SH groups using persistent eugonadism as referent. Adjustments were made for BMI, age, comorbidity burden (≥1 comorbidities), centre and smoking. Data are expressed as odds ratio ±95% confidence interval. The black, white and grey symbols denote the relation between incident SH and, respectively, the symptoms at baseline, at follow-up and their change (worsening/development) over time during follow-up. Level of statistical significance is denoted by: *P < .05, **P < .01 and ***P < .001. SH, secondary hypogonadism; LNSH, low total testosterone/normal free testosterone secondary hypogonadism; LLSH, low total testosterone/ low free testosterone secondary hypogonadism, BMI, Body Mass Index TT, total testosterone; FT, free testosterone; SH, secondary hypogonadism; LNSH, secondary hypogonadism with low total and normal free testosterone; LLSH, secondary hypogonadism with low total and low free testosterone.
a
The sum of 217 men (with persistent SH or recovery from SH to eugonadism) and 2 men (with SH at baseline and normal TT and low FT at follow-up) makes altogether the 219 men in the original recovery from SH group.
b
These men are part of those excluded from the analytical group either in the present or in the previously published 9 analytical groups due to primary hypogonadism at follow-up. These men were part of the original recovery from SH group 9 and now excluded due to normal TT and low FT at follow-up.
suggesting that it is a specious biochemical state (reflecting low SHBG) Obesity, especially when severe, can be associated with SH, characterized by low/normal LH and low FT despite the low SHBG.
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The mechanisms involved in gonadotrophin suppression are complex and poorly understood. These may include central leptin and insulin resistance as well as the inhibitory effect of pro-inflammatory cytokines on KNDY/GnRH neurons, which can impair directly or indirectly the HPT axis. [23] [24] [25] The hypothesized role of oestradiol excess in enhancing the negative feedback on HPT axis is controversial. 16, 26 Indeed, the putative increase in aromatase activity due to the expanded adipose tissue is not supported by data from our 16 and other studies, 27 which show that oestradiol, concurrently with T decline, is lower rather than higher, in obese men. There is also some evidence from in vitro studies that testicular steroidogenesis can be directly affected by adipocytokines, including leptin, TNF-α and decreased adiponectin. 28, 29 The mechanisms leading to the reduction in SHBG observed in obese men are also debated. Hyperinsulinemia and hyperglycaemia have been shown to inhibit SHBG synthesis by hepatocytes. 30, 31 Recent studies indicated that SHBG can be also down regulated by TNFα and IL1β and up regulated by adiponectin [32] [33] [34] ; these mechanisms, arising from low-grade chronic inflammation, may contribute to the lower serum SHBG associated with obesity.
| Strength and limitations
The main strengths of this study are the large sample of men representative of the European general population and the longitudinal design, which is less affected by confounders than crosssectional studies. The relatively small size of some of the analytical groups reflects the low incidence of hypogonadism in the general population, which may have been inflated by less rigorous studies.
Another strength is the use of standardized instruments throughout the EMAS centres and at both study phases. is impractical in large population-based epidemiological surveys. 36, 37 In this regard, T has been confirmed as a stable analyte without significant fluctuation within the same subject when measured serially over many months. [38] [39] [40] [41] Furthermore, the consistency of TT and LH levels between baseline and follow-up (respectively, r = .764 and .794, both P < .001) and the agreement between LH and FSH (r = .695
and .766, both P < .01, respectively, at baseline and follow-up) add credence to our results, making it unlikely that a single hormone determination would have introduced substantial misclassification of gonadal status.
| CON CLUS ION
These prospective data show that a subgroup of obese men characterized by low TT and low FT are prone to develop multiple sexual symptoms suggestive of androgen deficiency, in contrast to the majority of obese men with low TT (and low SHBG) but normal FT, who do not develop symptoms of hypogonadism. The latter group, which frequently remits spontaneously to eugonadism, is often incorrectly diagnosed to have (and treated for) hypogonadism. The use of FT in obesity can contribute to clinical practice by preventing the overdiagnosis of hypogonadism and minimizing inappropriate testosterone treatment.
